| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.091 | - | - | 20.909 | 21.958 | 15.378 | 16.167 | 23.971 | 29.451 | 33.471 |
| Total Income - EUR | 14.091 | - | - | 20.910 | 21.959 | 15.380 | 16.507 | 23.971 | 29.452 | 33.472 |
| Total Expenses - EUR | 12.658 | - | - | 17.455 | 17.686 | 9.199 | 14.814 | 18.908 | 27.296 | 31.879 |
| Gross Profit/Loss - EUR | 1.432 | - | - | 3.455 | 4.273 | 6.181 | 1.693 | 5.063 | 2.156 | 1.592 |
| Net Profit/Loss - EUR | 1.010 | - | - | 3.246 | 4.053 | 6.031 | 1.550 | 4.835 | 1.906 | 640 |
| Employees | 1 | - | - | 2 | 2 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Imodent Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 689 | - | - | 1.059 | 485 | 238 | 0 | 0 | 0 | 0 |
| Current Assets | 5.497 | - | - | 15.492 | 16.493 | 23.176 | 24.795 | 23.849 | 24.760 | 23.059 |
| Inventories | 2.768 | - | - | 2.171 | 946 | 264 | 714 | 1.562 | 5.669 | 10.017 |
| Receivables | 1.192 | - | - | 6.924 | 8.080 | 5.730 | 5.603 | 9.341 | 9.163 | 4.598 |
| Cash | 1.538 | - | - | 6.396 | 7.467 | 17.181 | 18.478 | 12.946 | 9.927 | 8.444 |
| Shareholders Funds | 5.494 | - | - | 11.645 | 15.473 | 21.210 | 22.290 | 20.807 | 22.650 | 18.759 |
| Social Capital | 45 | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 692 | - | - | 4.906 | 1.505 | 2.204 | 2.505 | 3.042 | 2.109 | 4.300 |
| Income in Advance | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Imodent Lab S.r.l.